|
|
||||||||
Enzymes and Protein Markers |
Departments of
1
Clinical Chemistry and
2
Medicine, Section for Cardiology, Rogaland Central Hospital, 4011 Stavanger, Norway.
a Author for correspondence. Fax 47-51519907.
We compared cardiac troponin I (cTnI), using Access®, Sanofi Pasteur, and cardiac troponin T (cTnT), using Elecsys®, Boehringer Mannheim, in the first two routine blood samplings in a routine panel of cardiac markers for the biochemical diagnostic evaluation of patients with symptoms of acute myocardial infarction (AMI). No significant differences in the overall clinical performances of cTnI and cTnT were observed for the diagnosis of AMI (n = 68), but cTnI demonstrated lower initial sensitivity and higher specificity compared with cTnT. cTnT was increased to higher relative values than cTnI (P = 0.023). Discordances were found between cTnI and cTnT in sample I but not in sample II; positive cTnT/negative cTnI was more common than the opposite discordance (P = 0.027). cTnT was more frequently increased in patients with unstable angina pectoris (UAP) than cTnI (P = 0.038), with no significant differences between sample I and sample II; discordant results with respect to cTnI and cTnT appeared in 6 (33%) of these patients, all of which were positive for cTnT and negative for cTnI. Four patients with UAP (22%) developed AMI within 4 months; three were associated with increased cTnI and cTnT at the time of initial testing, and one was discordant (positive cTnT). In patients classified with no acute coronary syndrome (n = 84), five concordant positives for cTnI and cTnT were observed, indicating the existence of a myocardial injury of recent origin in these patients. AMI evolved in one of these patients 5 months later. We conclude that cTnT and cTnI detect acute myocardial injury with equal clinical performance in AMI patients classified by WHO criteria. cTnT was more frequently increased in patients with UAP than cTnI, but the clinical significance of this discordance could not be determined from this study.
The following articles in journals at HighWire Press have cited this article:
![]() |
M. Rajappa and A. Sharma Biomarkers of Cardiac Injury: An Update Angiology, November 1, 2005; 56(6): 677 - 691. [Abstract] [PDF] |
||||
![]() |
S Clark, P Newland, C W Yoxall, and N V Subhedar Concentrations of cardiac troponin T in neonates with and without respiratory distress Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2004; 89(4): F348 - F352. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Douketis, M. A. Crowther, E. B. Stanton, and J. S. Ginsberg Elevated Cardiac Troponin Levels in Patients With Submassive Pulmonary Embolism Arch Intern Med, January 14, 2002; 162(1): 79 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
S J MAYNARD, I B A MENOWN, and A A J ADGEY Troponin T or troponin I as cardiac markers in ischaemic heart disease Heart, April 1, 2000; 83(4): 371 - 373. [Full Text] |
||||
![]() |
C. Heeschen, B. U. Goldmann, L. Langenbrink, G. Matschuck, and C. W. Hamm Evaluation of a Rapid Whole Blood ELISA for Quantification of Troponin I in Patients with Acute Chest Pain Clin. Chem., October 1, 1999; 45(10): 1789 - 1796. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |